Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load
Clinical trial NCT04121195 · COMPLETED
Trial details
- NCT number
- NCT04121195
- Sponsor
- University of Liverpool
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-30
- Primary completion
- 2022-05-20
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.